WORLD CANCER RESEARCH JOURNAL, cilt.9, ss.1-12, 2022 (ESCI)
Objective: Substance P (SP) is a neurotransmitter peptide, and it is known to play a major role in neurogenic inflammation, inducing local inflammatory responses, cancer, and angiogenesis. It has been previously demonstrated that SP possesses a wide range of pharmacological effects including induced cancer cell proliferation and triggered angiogenic response of tumors. However, there is no published work regarding the proliferative effects of its physiological fragments [N-terminal fragment SP (1-7) and C-terminal fragment SP (9-11)] not only on cancer cells but also on human umbilical vein endothelial cells (HUVECs).